Business
Australian shares to rise as COVID vaccine euphoria pushes Wall Street to new records – ABC News
Australian shares are expected to rise for the seventh day in a row, as global markets received another shot of COVID-19 vaccine optimism from Pfizer, Johnson &…
Australian shares are expected to rise for the seventh day in a row, as global markets received another shot of COVID-19 vaccine optimism.
ASX futures were up 31 points (+0.5pc) by 8:10am AEDT.
Johnson & Johnson announced it could obtain late-stage trial results of a single-dose coronavirus vaccine it is developing, earlier than expected. That sent its US-listed shares up 1.6 per cent.
Another US pharmaceutical giant, Pfizer, has cleared the next hurdle in the race to get its vaccine approved for…
-
Noosa News23 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
Business21 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
Business23 hours agoWhy this investing expert is calling time on NAB shares
-
General19 hours agoFederal government funding extends cohealth GP services until July 2026